SKF-83,959
From Wikipedia, the free encyclopedia
| Systematic (IUPAC) name | |
|---|---|
| 6-chloro-7,8-dihydroxy-3-methyl-1-(3-methylphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| ATC code | ? |
| PubChem | CID 24278699 |
| ChemSpider | 10131933 |
| ChEMBL | CHEMBL520992 |
| Chemical data | |
| Formula | C18H20ClNO2 |
| Mol. mass | 317.810 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
SKF-83,959 is a synthetic benzazepine derivative used in scientific research which acts as a selective D1 receptor antagonist and D5 receptor full agonist, as evidenced by the fact that it has high affinity for both receptors and stimulates the D5-linked PLC/PI second messenger pathway without affecting the cAMP/AC pathway which is linked to D1.[1][2][3][4]
[edit] References
- ^ Jin LQ, Goswami S, Cai G, Zhen X, Friedman E (April 2003). "SKF83959 selectively regulates phosphatidylinositol-linked D1 dopamine receptors in rat brain". Journal of Neurochemistry 85 (2): 378–86. PMID 12675914.
- ^ Zhen X, Goswami S, Friedman E (April 2005). "The role of the phosphatidyinositol-linked D1 dopamine receptor in the pharmacology of SKF83959". Pharmacology, Biochemistry, and Behavior 80 (4): 597–601. doi:10.1016/j.pbb.2005.01.016. PMID 15820529.
- ^ Zhang ZJ, Jiang XL, Zhang SE, Hough CJ, Li H, Chen JG, Zhen XC (2005). "The paradoxical effects of SKF83959, a novel dopamine D1-like receptor agonist, in the rat acoustic startle reflex paradigm". Neuroscience Letters 382 (1-2): 134–8. doi:10.1016/j.neulet.2005.03.001. PMID 15911136.
- ^ Sahu A, Tyeryar KR, Vongtau HO, Sibley DR, Undieh AS (March 2009). "D5 dopamine receptors are required for dopaminergic activation of phospholipase C". Molecular Pharmacology 75 (3): 447–53. doi:10.1124/mol.108.053017. PMID 19047479. http://molpharm.aspetjournals.org/cgi/pmidlookup?view=long&pmid=19047479.
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |

